Log in
RegisterAUCrefTmax (Health Canada) [Regulatives / Guidelines]
posted by Helmut 
– Vienna, Austria, 2021-05-28 14:58 (1062 d 14:32 ago) – Posting: # 22377
Views: 1,548
Hi raghup,
❝ For an NSAID immediate release Soft gelatin capsules with two way crossover study although if AUCt and Cmax are with in acceptance limits and there is no difference in median Tmax of both Test and Reference, but for AUCrefTmax 90% CI is not within 80-125% (will Health Canada accept the BE study).
- Rapid onset of effect is important. According to the guidance AUCrefTmax should be reported.
IMHO, a statistical comparison is not required.
- For Cmax only the point estimate has to lie within 80.0–125.0%.
If the CI passes 80.0–125.0%, nice to know but not required.
- What does you protocol say?
—
Dif-tor heh smusma 🖖🏼 Довге життя Україна!![[image]](https://static.bebac.at/pics/Blue_and_yellow_ribbon_UA.png)
Helmut Schütz
![[image]](https://static.bebac.at/img/CC by.png)
The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes
Dif-tor heh smusma 🖖🏼 Довге життя Україна!
Helmut Schütz
The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes
Complete thread:
- AUCrefTmax raghup 2021-05-28 12:44 [Regulatives / Guidelines]
![[Mix]](https://static.bebac.at/img/mix.png "open in Mix view")
- AUCrefTmax (Health Canada)Helmut 2021-05-28 12:58
- AUCrefTmax (Health Canada) raghup 2021-05-28 13:16
- AUCrefTmax (Health Canada) Helmut 2021-05-28 13:23
- AUCrefTmax (Health Canada) dshah 2021-05-31 10:15
- AUCrefTmax (Health Canada) raghup 2021-05-28 13:16
- AUCrefTmax (Health Canada)Helmut 2021-05-28 12:58
Ing. Helmut Schütz